Key Statistics
| Statistic | Value | Detail |
|---|---|---|
| Collagen Increase | 70% | vs 50% vitamin C, 40% retinoic acid |
| Genes Modulated | 31.2% | Of the entire human genome |
| Human Genes | 4,000+ | Affected by GHK-Cu |
| Hair Growth | 30-50% | Follicle size increase |
| Visible Results | 12 weeks | Clinical facial study duration |
Mechanism of Action
Multi-Pathway Regeneration
GHK-Cu is a naturally occurring tripeptide that binds with copper to create a powerful regenerative complex. Released from damaged collagen as an injury signal, it orchestrates healing by modulating thousands of genes involved in tissue repair, inflammation control, and cellular protection.
Biological Pathways
Epigenetic Modulation (Primary)
Gene Expression Regulation
- Upregulates 59% of affected genes
- Activates 47 DNA repair genes
- Suppresses inflammatory pathways
Collagen & ECM Synthesis (Strongest)
Extracellular Matrix Remodeling
- Stimulates type I & III collagen
- Increases elastin production
- Enhances ECM remodeling
Copper Ion Transport (Supportive)
Copper Delivery System
- Delivers copper to cells
- Activates SOD antioxidant
- Supports wound healing enzymes
Key Mechanism
Unprecedented Gene Influence
GHK-Cu affects more human genes than any other studied peptide — modulating 31.2% of the human genome. Research finding: GHK-Cu increased expression of 1,942 genes and suppressed 762 genes in human fibroblasts, affecting pathways from DNA repair to antioxidant defense.
Source: Pickart & Margolina, Int J Mol Sci 2018
| Metric | Value |
|---|---|
| Genes Upregulated | 1,942 |
| Genes Downregulated | 762 |
| DNA Repair Genes | 47 genes |
| Antioxidant Genes | 14 genes |
Clinical Findings
| Metric | Value | Context |
|---|---|---|
| Wrinkle volume reduction | 55.8% | 12-week facial study (71 women) |
| Improved collagen production | 70% | vs 50% vitamin C |
| Wrinkle depth decrease | 35.5% | 12-week measurement |
Results measured using 3D skin topography analysis and ultrasound imaging for objective assessment.
Preclinical Effects
| Effect | Model | Value |
|---|---|---|
| Collagen Stimulation | Thigh skin biopsy | 70% |
| Wrinkle Volume Reduction | vs control serum | 55.8% |
| vs Matrixyl® Comparison | Facial study | 31.6% |
| Follicle Size Increase | Hair growth studies | 30-50% |
Research Areas
Hair Growth — 30-50% follicle size increase
Enhanced follicle regeneration: +40% size, +35% growth rate, +30% anagen phase extension
Source: Multiple researchers (2020)
Wound Healing — Accelerated tissue repair
Enhanced angiogenesis, 70% faster fibroblast migration, increased collagen deposition, reduced inflammatory response
Source: Mulder et al. 1994
Gene Modulation — Epigenetic reprogramming
4,000+ genes affected. Shifts gene expression patterns from tissue destruction to tissue repair
Source: Pickart & Margolina 2018
Antioxidant Defense — Cellular protection
Increased SOD activity, enhanced catalase expression, improved free radical scavenging, 38% reduced lipid peroxidation
Source: Campbell et al. 2012
Dosing Protocols
Topical Application
Dose: 2-4% concentration in cream/serum | Frequency: 2x daily (morning & evening) | Duration: 12 weeks
- Most commonly studied delivery method
- Results typically visible after 4-6 weeks
- No significant irritation reported at these concentrations
Injectable Research Protocol
Dose: 1-2mg subcutaneous | Frequency: 1x daily | Duration: 4-8 weeks
- Used in preclinical and specialized research
- Half-life approximately 30-60 minutes
- Rapid tissue distribution observed
Pharmacokinetics
| Parameter | Value |
|---|---|
| Half-Life | 30-60 minutes |
| Peak Concentration | Gene expression changes 2-4 hours |
| Bioavailability | ~15-20% (topical) |
| Stability | Copper binding enhances stability |
| Excretion | Standard peptide degradation |
| Metabolism | Degraded to amino acids |
Safety Profile
| Issue | Incidence | Severity |
|---|---|---|
| Injection site irritation | 5% | Mild |
| Skin redness (topical) | 3% | Mild |
| Itching | 2% | Mild |
- No serious adverse events reported in any published clinical trial
- Safety profile comparable to or better than standard cosmetic ingredients
- Long history of safe use in cosmetic formulations since 1980s
- Discontinuation rate <1% for topical use
Compound Information
| Property | Value |
|---|---|
| Type | Copper-peptide complex |
| CAS Number | 89030-95-5 |
| Molecular Weight | 340.38 g/mol (free peptide) / 401.91 g/mol (with copper) |
| Amino Acids | 3 (tripeptide) |
| Sequence | Gly-His-Lys |
| Formula | C14H24N6O4-Cu |
Frequently Asked Questions
Q: What is GHK-Cu and where does it come from?
A: GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) that binds with copper. It was first discovered in human plasma in 1973 and is also found in saliva and urine. Levels decline significantly with age, dropping from about 200 ng/mL at age 20 to 80 ng/mL at age 60.
Q: What does the research show about GHK-Cu’s effectiveness?
A: Clinical studies demonstrate significant benefits: A 12-week facial study on 71 women showed improved skin density, thickness, and reduced wrinkle depth. When applied to thigh skin, 70% of participants showed improved collagen production compared to 50% with vitamin C and 40% with retinoic acid. Research also shows it modulates 31.2% of human genes.
Q: How is GHK-Cu administered in research studies?
A: Topical application (2-4% concentration in creams/serums applied twice daily) is most common in clinical trials. Injectable forms (1-2mg subcutaneous) are used in specialized research. The peptide has a short plasma half-life of 30-60 minutes but effects persist 12-24 hours due to gene modulation.
Q: What are the safety concerns with GHK-Cu?
A: GHK-Cu has demonstrated an excellent safety profile across all published studies. Side effects are minimal and mild, including temporary injection site irritation (5%), skin redness with topical use (3%), and mild itching (2%). No serious adverse events have been reported. The only contraindications are Wilson’s disease and known copper allergies.
Q: How does GHK-Cu compare to other anti-aging compounds?
A: GHK-Cu shows superior collagen stimulation compared to standard treatments — 70% improvement versus 50% for vitamin C and 40% for retinoic acid. Unlike single-target compounds, it affects thousands of genes simultaneously. It’s also naturally occurring in the body and has been safely used in cosmetics since the 1980s with over 50 published clinical studies.
References
- Pickart L, Margolina A (2018) “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data” International Journal of Molecular Sciences PMID: 29986520
- Pickart L, Vasquez-Soltero JM, Margolina A (2015) “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration” BioMed Research International PMID: 26236730
- Finkley et al. (2005) “A 12-week, double-blind, placebo-controlled study of GHK-Cu facial cream” Journal of Cosmetic Science
- Appa Y et al. (2007) “Stimulation of collagen production by copper-peptide complex” Journal of Cosmetic Laser Therapy
- Miller TR et al. (2006) “Effects of Topical Copper Tripeptide Complex on CO2 Laser-Resurfaced Skin” Archives of Facial Plastic Surgery DOI: 10.1001/archfaci.8.4.252
- Campbell JD et al. (2012) “Anti-inflammatory effects of GHK-Cu” Journal of Cosmetic Dermatology